Cowen & Co. analyst Joseph Giordano upgrades IDEX (NYSE:IEX) from Market Perform to Outperform.
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $70 to $65.